✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
At present, there is no proved treatment for this disease
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Scleredema is a rare connective tissue disorder of unknown pathogenesis.
📊
Key Findings & Data:The patient was followed regularly for 13 years and did not respond to various combinations of immunosuppressants and psoralen plus ultraviolet A therapy.
💡
Conclusion & Impact:At present, there is no proved treatment for this disease
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Scleredema is a rare connective tissue disorder of unknown pathogenesis. Three types of scleredema have been described, based on its association with postinfection, monoclonal gammopathy and diabetes mellitus. We report herein a case of scleredema which the diagnosis didn't get specified. The patient was followed regularly for 13 years and did not respond to various combinations of immunosuppressants and psoralen plus ultraviolet A therapy. Treatment of scleredema is quite difficult and of limited success. At present, there is no proved treatment for this disease
🔖
Cite This Article
ZİHNİ, F. Y., KARABULUT, G., KOÇANAOĞULLARI, H., İNAL, V., KALFA, M., EMMUNGİL, H. (2022). Therapy resistant idiopathic scleredema: an underlying pathology not always present. European Journal of Rheumatology, Cilt: 2 - Sayı: 4, 163–164. https://ajindex.com/articles/511813